Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll PSA and beyond: the past, present, and future of investigative biomarkers for prostate cancer Tosoian J; Loeb SScientificWorldJournal 2010[Oct]; 10 (ä): 1919-31The discovery of prostate-specific antigen (PSA) as a biomarker represented a major discovery in the early diagnosis and monitoring of prostate cancer. However, the use of PSA is limited by the lack of specificity and an inability to differentiate indolent from life-threatening disease reliably at the time of diagnosis. A multitude of studies have aimed to improve the performance of PSA as well as identify additional biomarkers. The purpose of this study is to review available data on prostate cancer biomarkers for prostate cancer screening and prognostication, including prostatic acid phosphatase, PSA, PSA derivatives (PSA density, free PSA, pro PSA, and PSA kinetics), PCA3, GSTP1, AMACR, and other newly emerging molecular and genetic markers.|Biomarkers, Tumor/*analysis/genetics[MESH]|Forecasting[MESH]|Genetic Predisposition to Disease/genetics[MESH]|Genome-Wide Association Study/methods/trends[MESH]|Humans[MESH]|Male[MESH]|Polymorphism, Single Nucleotide[MESH]|Prostate-Specific Antigen/*analysis/genetics[MESH]|Prostatic Neoplasms/*diagnosis/genetics/metabolism[MESH]|Sensitivity and Specificity[MESH] |